References
- Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986: 315(4): 209–14
- Centers for Disease Control. Advisory Committee on Immunization Practices: recommendations for protection against viral hepatitis. MMWR 1985: 34(22): 313–24, 329–35
- McLean AA. Development of vaccines against hepatitis A and hepatitis B. Rev Infect Dis 1986: 8(4): 591–8
- Centers for Disease Control. Hepatitis surveillance report No. 50. Washington. DC: US Gov Print Off, 1986: 16–25
- Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980: 303(15): 833–41
- Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med 1982: 307(24): 1481–6
- Stevens CE, Taylor FE, Rubinstein P, et al. Safety of the hepatitis B vaccine. (Letter) N Engl J Med 1985: 312(6): 375–6
- Dienstag JL, Werner BG, McLane MP, et al. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. JAMA 1985: 254(8): 1064–6
- Francis DP, Feorino PM, McDoogal S, et al. The safety of the hepatitis B vaccine: inactivation of the AIDS virus during routine vaccine manufacture. JAMA 1986: 256(7): 869–72
- Emini EA, Ellis RW, Miller WJ, et al. Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986: 13(Suppl A): 3–9
- Papaevangelou G, Dandolos E, Roumeliotou-Karayannia A, et al. Immunogenicity of recombinant hepatitis B vaccine. (Letter) Lancet 1985: 1(8426): 455–6
- Brown SE, Stanley C, Howard CR, et al. Antibody responses to recombinant and plasma derived hepatitis B vaccines. Br Med J (Clin Res) 1986: 292(6514): 159–61
- Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987: 257(19): 2612–6
- Hollinger FB, Troisi CL, Pepe PE. Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast. J Infect Dis 1986: 153(1): 156–9
- Dandolos E, Roumeliotou-Kanyannis A, Richardson SC, et al. Safety and immunogenicity of a recombinant hepatitis B vaccine. J Med Virol 1985: 17(1): 57–62
- Centers for Disease Control. Advisory Committee on Immunization Practices: update on hepatitis B prevention. MMWR 1987: 36(23): 353–60, 366
- Kumar ML, Dawson NV, McCullough AJ, et al. Should all pregnant women be screened for hepatitis B? Ann Intern Med 1987: 107(3): 273–7
- Arevalo JA, Washington AE. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA 1988: 259(3): 365–9
- Stevens CE, Neurath RA, Beasley HP, et al. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979: 3(3): 237–41
- Beasley RP, Hwang LT, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981: 2(8256): 1129–33
- Vyas GN. A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes. Dev Biol Stand 1986: 63: 141–6
- Zuckerman AJ. Subunit, recombinant and synthetic hepatitis B vaccines. Scand J Gastroenterol (Suppl) 1985: 117: 27–38
- Tabor E. The three viruses of non-A, non-B hepatitis. Lancet 1985: 1(8431): 743–5
- Smedile A, Rizzetto M. The hepatitis delta virus and its disease. Viewpoints Dig Dis 1987: 19(1): 1–4
- Rizzetto M, Verme G, Gerin JL, et al. Hepatitis delta virus disease. Prog Liver Dis 1986: 8: 417–31